The most recent insider trading activity at NextCure Inc. occurred on November 15, 2019, with a significant buy transaction by Sofinnova Venture Partners IX, L.P. This transaction involved 150,000 shares valued at $5,512,500. Prior to this, several other buy transactions took place in May 2019, indicating consistent insider purchasing.